[1]IZQUIERDO-SANCHEZ L,LAMARCA A,LA CA,et al.Cholangiocarcinoma landscape in Europe:diagnostic,prognostic and therapeutic insights from the ENSCCA Registry[J].J Hepatol,2022,76(5):1109-1121.
[2]BRINDLEY PJ,BACHINI M,ILYAS SI,et al.Cholangiocarcinoma[J].Nat Rev Dis Primers,2021,7(1):65.
[3]SCHUBERT D,KLAR A,PARK M,et al.F-spondin promotes nerve precursor differentiation[J].J Neurochem,2006,96(2):444-453.
[4]KLAR A,BALDASSARE M,JESSELL TM.F-spondin:a gene expressed at high levels in the floor plate encodes a secreted protein that promotes neural cell adhesion and neurite extension[J].Cell,1992,69(1):95-110.
[5]CLEMITSON JR,DIXON RJ,HAINES S,et al.Genetic dissection of a blood pressure quantitative trait locus on rat chromosome 1 and gene expression analysis identifies SPON1 as a novel candidate hypertension gene[J].Circ Res,2007,100(7):992-999.
[6]CHANG HP,DONG TH,MA XT,et al.Spondin 1 promotes metastatic progression through Fak and Src dependent pathway in human osteosarcoma[J].Biochem Biophys Res Commun,2015,464(1):45-50.
[7]DAI W,HUANG HL,HU M,et al.MicroRNA-506 regulates proliferation,migration and invasion in hepatocellular carcinoma by targeting F-spondin 1 (SPON1)[J].Am J Cancer Res,2015,5(9):2697-2707.
[8]NAGASAWA S,IKEDA K,SHINTANI D,et al.SPON1-TRIM29 identification of a novel oncogenic fusion gene in clinical ovarian cancer that promotes cell and tumor growth and enhances chemoresistance in A2780 cells[J].Int J Mol Sci,2022,23(2):689.
[9]TAMJIDIFAR R,AKBARI M,TARZI S,et al.Prognostic and diagnostic values of miR-506 and SPON 1 in colorectal cancer with clinicopathological considerations[J].J Gastrointest Cancer,2021,52(1):125-129.
[10]HUO YM,YANG J,ZHENG JH,et al.Increased SPON1 promotes pancreatic ductal adenocarcinoma progression by enhancing IL-6 trans-signalling[J].Cell Prolif,2022,55(5):e13237.
[11]WU QB,ZHEN YL,SHI L,et al.EGFR inhibition potentiates FGFR inhibitor therapy and overcomes resistance in FGFR2 fusion-positive cholangiocarcinoma[J].Cancer Discov,2022,12(5):1378-1395.
[12]SAHAI V,CATALANO PJ,ZALUPSKI MM,et al.Nab-paclitaxel and gemcitabine as first-line treatment of advanced or metastatic cholangiocarcinoma:a phase 2 clinical trial[J].JAMA Oncol,2018,4(12):1707-1712.
[13]HU HS,XIN N,LIU JX,et al.Characterization of F-spondin in Japanese flounder (Paralichthys olivaceus) and its role in the nervous system development of teleosts[J].Gene,2016,575:623-631.
[14]LV J,ZHU YZ,JI AL,et al.Mining TCGA database for tumor mutation burden and their clinical significance in bladder cancer[J].Biosci Rep,2020,40(4):BSR20194337.
[15]VAQUERO J,GUEDJ N,CLAPRON A,et al.Epithelial-mesenchymal transition in cholangiocarcinoma:From clinical evidence to regulatory networks[J].J Hepatol,2017,66(2):424-441.
[16]LIU B,SONG XD,YAN ZW,et al.MicroRNA-525 enhances chondrosarcoma malignancy by targeting F-spondin 1[J].Oncol Lett,2019,17(1):781-788.